Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs United States Oil ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 3.2× United States Oil ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, United States Oil ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and United States Oil ETF for 21 Days on average.
| IOVA | USO | |
|---|---|---|
Market Cap | $6.04B | $1.90B |
Volume | 14,805,993 | 5,932,922 |
Sector | Health | — |
52-Week High | $14.82 | $161.86 |
52-Week Low | $1.81 | $66.17 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $5.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USO shows strong momentum with a 2.98% gain to $148.20, supported by bullish technical signals including positive moving averages and key resistance at $150. The oil sector faces mixed fundamentals with OPEC+ maintaining steady output while geopolitical tensions in the Middle East create supply uncertainty. Recent news highlights attacks on oil infrastructure and G-7 reserve releases impacting global oil markets.
The stock presents upside potential toward $152-154 resistance levels, though risks include oil price volatility from geopolitical events and potential supply disruptions. Investor sentiment remains cautiously optimistic given the technical strength, but fundamental clarity on earnings and margins is needed for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
